UniProt ID | PSD12_HUMAN | |
---|---|---|
UniProt AC | O00232 | |
Protein Name | 26S proteasome non-ATPase regulatory subunit 12 | |
Gene Name | PSMD12 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 456 | |
Subcellular Localization | ||
Protein Description | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair.. | |
Protein Sequence | MADGGSERADGRIVKMEVDYSATVDQRLPECAKLAKEGRLQEVIETLLSLEKQTRTASDMVSTSRILVAVVKMCYEAKEWDLLNENIMLLSKRRSQLKQAVAKMVQQCCTYVEEITDLPIKLRLIDTLRMVTEGKIYVEIERARLTKTLATIKEQNGDVKEAASILQELQVETYGSMEKKERVEFILEQMRLCLAVKDYIRTQIISKKINTKFFQEENTEKLKLKYYNLMIQLDQHEGSYLSICKHYRAIYDTPCIQAESEKWQQALKSVVLYVILAPFDNEQSDLVHRISGDKKLEEIPKYKDLLKLFTTMELMRWSTLVEDYGMELRKGSLESPATDVFGSTEEGEKRWKDLKNRVVEHNIRIMAKYYTRITMKRMAQLLDLSVDESEAFLSNLVVNKTIFAKVDRLAGIINFQRPKDPNNLLNDWSQKLNSLMSLVNKTTHLIAKEEMIHNLQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MADGGSERA ------CCCCCCCCC | 24.93 | 19413330 | |
6 | Phosphorylation | --MADGGSERADGRI --CCCCCCCCCCCCE | 29.46 | 29514088 | |
16 | Sulfoxidation | ADGRIVKMEVDYSAT CCCCEEEEEEECCCC | 4.15 | 21406390 | |
20 | Phosphorylation | IVKMEVDYSATVDQR EEEEEEECCCCCCCC | 12.84 | 28796482 | |
21 | Phosphorylation | VKMEVDYSATVDQRL EEEEEECCCCCCCCC | 17.01 | 28796482 | |
23 | Phosphorylation | MEVDYSATVDQRLPE EEEECCCCCCCCCHH | 20.76 | 28796482 | |
33 | Acetylation | QRLPECAKLAKEGRL CCCHHHHHHHHHCCH | 61.71 | 25953088 | |
33 | Malonylation | QRLPECAKLAKEGRL CCCHHHHHHHHHCCH | 61.71 | 32601280 | |
33 | Ubiquitination | QRLPECAKLAKEGRL CCCHHHHHHHHHCCH | 61.71 | - | |
36 | Ubiquitination | PECAKLAKEGRLQEV HHHHHHHHHCCHHHH | 71.75 | - | |
52 | Ubiquitination | ETLLSLEKQTRTASD HHHHHHHHHCCCHHH | 63.36 | 21890473 | |
56 | Phosphorylation | SLEKQTRTASDMVST HHHHHCCCHHHHHCH | 33.62 | 20068231 | |
58 | Phosphorylation | EKQTRTASDMVSTSR HHHCCCHHHHHCHHH | 26.15 | 20068231 | |
60 | Sulfoxidation | QTRTASDMVSTSRIL HCCCHHHHHCHHHHH | 2.07 | 30846556 | |
62 | Phosphorylation | RTASDMVSTSRILVA CCHHHHHCHHHHHHH | 17.64 | 24114839 | |
64 | Phosphorylation | ASDMVSTSRILVAVV HHHHHCHHHHHHHHH | 15.15 | 24114839 | |
88 | Sulfoxidation | DLLNENIMLLSKRRS HHHCHHHHHHHHHHH | 4.67 | 30846556 | |
92 | Sumoylation | ENIMLLSKRRSQLKQ HHHHHHHHHHHHHHH | 52.37 | - | |
92 | Sumoylation | ENIMLLSKRRSQLKQ HHHHHHHHHHHHHHH | 52.37 | 25114211 | |
92 | Ubiquitination | ENIMLLSKRRSQLKQ HHHHHHHHHHHHHHH | 52.37 | - | |
98 | 2-Hydroxyisobutyrylation | SKRRSQLKQAVAKMV HHHHHHHHHHHHHHH | 28.68 | - | |
98 | Acetylation | SKRRSQLKQAVAKMV HHHHHHHHHHHHHHH | 28.68 | 25953088 | |
98 | Succinylation | SKRRSQLKQAVAKMV HHHHHHHHHHHHHHH | 28.68 | 23954790 | |
98 | Ubiquitination | SKRRSQLKQAVAKMV HHHHHHHHHHHHHHH | 28.68 | - | |
103 | Ubiquitination | QLKQAVAKMVQQCCT HHHHHHHHHHHHHHH | 32.76 | - | |
104 | Sulfoxidation | LKQAVAKMVQQCCTY HHHHHHHHHHHHHHH | 2.07 | 30846556 | |
109 | Glutathionylation | AKMVQQCCTYVEEIT HHHHHHHHHHHHHHH | 2.40 | 22555962 | |
111 | Phosphorylation | MVQQCCTYVEEITDL HHHHHHHHHHHHHCC | 7.61 | - | |
121 | Ubiquitination | EITDLPIKLRLIDTL HHHCCCHHHHHHHHH | 26.14 | 21890473 | |
127 | Phosphorylation | IKLRLIDTLRMVTEG HHHHHHHHHHHHHCC | 14.85 | 23898821 | |
132 | Phosphorylation | IDTLRMVTEGKIYVE HHHHHHHHCCCEEEE | 29.67 | 23898821 | |
137 | Phosphorylation | MVTEGKIYVEIERAR HHHCCCEEEEEEHHH | 8.77 | 20393185 | |
147 | Malonylation | IERARLTKTLATIKE EEHHHHHHHHHHHHH | 46.24 | 32601280 | |
147 | Ubiquitination | IERARLTKTLATIKE EEHHHHHHHHHHHHH | 46.24 | 21890473 | |
148 | Phosphorylation | ERARLTKTLATIKEQ EHHHHHHHHHHHHHH | 19.18 | 21406692 | |
151 | Phosphorylation | RLTKTLATIKEQNGD HHHHHHHHHHHHCCC | 35.38 | 21406692 | |
153 | Ubiquitination | TKTLATIKEQNGDVK HHHHHHHHHHCCCHH | 49.22 | 21890473 | |
160 | Ubiquitination | KEQNGDVKEAASILQ HHHCCCHHHHHHHHH | 46.50 | 21890473 | |
162 | Acetylation | QNGDVKEAASILQEL HCCCHHHHHHHHHHH | 10.78 | 19608861 | |
162 | Ubiquitination | QNGDVKEAASILQEL HCCCHHHHHHHHHHH | 10.78 | 19608861 | |
164 | Phosphorylation | GDVKEAASILQELQV CCHHHHHHHHHHHHC | 30.77 | 27080861 | |
173 | Phosphorylation | LQELQVETYGSMEKK HHHHHCCCCCCCCHH | 34.03 | 30108239 | |
174 | Nitration | QELQVETYGSMEKKE HHHHCCCCCCCCHHH | 8.16 | - | |
174 | Phosphorylation | QELQVETYGSMEKKE HHHHCCCCCCCCHHH | 8.16 | 27080861 | |
176 | Phosphorylation | LQVETYGSMEKKERV HHCCCCCCCCHHHHH | 17.23 | 30576142 | |
177 | Sulfoxidation | QVETYGSMEKKERVE HCCCCCCCCHHHHHH | 8.32 | 30846556 | |
179 | Ubiquitination | ETYGSMEKKERVEFI CCCCCCCHHHHHHHH | 51.82 | 21890473 | |
192 | Ubiquitination | FILEQMRLCLAVKDY HHHHHHHHHHHHHHH | 2.05 | 21890473 | |
197 | 2-Hydroxyisobutyrylation | MRLCLAVKDYIRTQI HHHHHHHHHHHHHHH | 38.93 | - | |
197 | Acetylation | MRLCLAVKDYIRTQI HHHHHHHHHHHHHHH | 38.93 | 27452117 | |
197 | Ubiquitination | MRLCLAVKDYIRTQI HHHHHHHHHHHHHHH | 38.93 | - | |
201 | Acetylation | LAVKDYIRTQIISKK HHHHHHHHHHHHHHH | 17.85 | 19608861 | |
201 | Ubiquitination | LAVKDYIRTQIISKK HHHHHHHHHHHHHHH | 17.85 | 19608861 | |
206 | Phosphorylation | YIRTQIISKKINTKF HHHHHHHHHHHCCHH | 29.53 | 24719451 | |
207 | 2-Hydroxyisobutyrylation | IRTQIISKKINTKFF HHHHHHHHHHCCHHH | 47.46 | - | |
212 | 2-Hydroxyisobutyrylation | ISKKINTKFFQEENT HHHHHCCHHHCCCCC | 39.43 | - | |
212 | Acetylation | ISKKINTKFFQEENT HHHHHCCHHHCCCCC | 39.43 | 26051181 | |
212 | Malonylation | ISKKINTKFFQEENT HHHHHCCHHHCCCCC | 39.43 | 26320211 | |
212 | Ubiquitination | ISKKINTKFFQEENT HHHHHCCHHHCCCCC | 39.43 | 21890473 | |
219 | Phosphorylation | KFFQEENTEKLKLKY HHHCCCCCHHHHHEE | 37.46 | - | |
221 | Acetylation | FQEENTEKLKLKYYN HCCCCCHHHHHEEEE | 49.21 | 19608861 | |
221 | Ubiquitination | FQEENTEKLKLKYYN HCCCCCHHHHHEEEE | 49.21 | 21906983 | |
227 | Phosphorylation | EKLKLKYYNLMIQLD HHHHHEEEEEEEEEC | 10.55 | 18452278 | |
251 | Phosphorylation | CKHYRAIYDTPCIQA HHHHHHHHCCCCHHH | 16.87 | 20068231 | |
253 | Phosphorylation | HYRAIYDTPCIQAES HHHHHHCCCCHHHCC | 11.77 | 20068231 | |
255 | S-nitrosocysteine | RAIYDTPCIQAESEK HHHHCCCCHHHCCHH | 3.80 | - | |
255 | S-nitrosylation | RAIYDTPCIQAESEK HHHHCCCCHHHCCHH | 3.80 | 19483679 | |
262 | Acetylation | CIQAESEKWQQALKS CHHHCCHHHHHHHHH | 60.63 | 25038526 | |
262 | Ubiquitination | CIQAESEKWQQALKS CHHHCCHHHHHHHHH | 60.63 | - | |
295 | Ubiquitination | HRISGDKKLEEIPKY HHHCCCCCHHHCCCH | 66.91 | - | |
301 | Ubiquitination | KKLEEIPKYKDLLKL CCHHHCCCHHHHHHH | 71.27 | - | |
309 | Acetylation | YKDLLKLFTTMELMR HHHHHHHHHHHHHHH | 5.23 | 19608861 | |
312 | Sulfoxidation | LLKLFTTMELMRWST HHHHHHHHHHHHHHH | 3.19 | 21406390 | |
326 | Sulfoxidation | TLVEDYGMELRKGSL HHHHHHCCCCCCCCC | 3.40 | 30846556 | |
330 | Ubiquitination | DYGMELRKGSLESPA HHCCCCCCCCCCCCC | 66.53 | 21890473 | |
332 | Phosphorylation | GMELRKGSLESPATD CCCCCCCCCCCCCCC | 31.81 | 29255136 | |
335 | Phosphorylation | LRKGSLESPATDVFG CCCCCCCCCCCCCCC | 25.73 | 29255136 | |
338 | Phosphorylation | GSLESPATDVFGSTE CCCCCCCCCCCCCCH | 35.76 | 25850435 | |
343 | Phosphorylation | PATDVFGSTEEGEKR CCCCCCCCCHHHHHH | 22.60 | 30622161 | |
344 | Phosphorylation | ATDVFGSTEEGEKRW CCCCCCCCHHHHHHH | 38.13 | 30622161 | |
348 | Acetylation | FGSTEEGEKRWKDLK CCCCHHHHHHHHHHH | 42.60 | 19608861 | |
349 | 2-Hydroxyisobutyrylation | GSTEEGEKRWKDLKN CCCHHHHHHHHHHHH | 74.54 | - | |
349 | Ubiquitination | GSTEEGEKRWKDLKN CCCHHHHHHHHHHHH | 74.54 | - | |
368 | Acetylation | HNIRIMAKYYTRITM HHHHHHHHHHHHHHH | 22.78 | 19608861 | |
368 | Malonylation | HNIRIMAKYYTRITM HHHHHHHHHHHHHHH | 22.78 | 26320211 | |
368 | Ubiquitination | HNIRIMAKYYTRITM HHHHHHHHHHHHHHH | 22.78 | 19608861 | |
369 | Phosphorylation | NIRIMAKYYTRITMK HHHHHHHHHHHHHHH | 10.67 | 25884760 | |
370 | Phosphorylation | IRIMAKYYTRITMKR HHHHHHHHHHHHHHH | 6.71 | 25884760 | |
389 | Acetylation | LDLSVDESEAFLSNL HCCCCCCCHHHHHHH | 29.75 | 19608861 | |
389 | Ubiquitination | LDLSVDESEAFLSNL HCCCCCCCHHHHHHH | 29.75 | 19608861 | |
401 | Phosphorylation | SNLVVNKTIFAKVDR HHHCCCCCHHHHHHH | 19.00 | 23403867 | |
405 | Succinylation | VNKTIFAKVDRLAGI CCCCHHHHHHHHHCC | 33.64 | 23954790 | |
419 | Acetylation | IINFQRPKDPNNLLN CCCCCCCCCCCCHHH | 84.06 | 26822725 | |
419 | Ubiquitination | IINFQRPKDPNNLLN CCCCCCCCCCCCHHH | 84.06 | - | |
428 | Ubiquitination | PNNLLNDWSQKLNSL CCCHHHHHHHHHHHH | 11.11 | 21890473 | |
428 | Acetylation | PNNLLNDWSQKLNSL CCCHHHHHHHHHHHH | 11.11 | 19608861 | |
428 | Ubiquitination | PNNLLNDWSQKLNSL CCCHHHHHHHHHHHH | 11.11 | 19608861 | |
431 | Ubiquitination | LLNDWSQKLNSLMSL HHHHHHHHHHHHHHH | 44.09 | - | |
434 | Phosphorylation | DWSQKLNSLMSLVNK HHHHHHHHHHHHHHH | 35.57 | 21712546 | |
436 | Sulfoxidation | SQKLNSLMSLVNKTT HHHHHHHHHHHHHHH | 2.67 | 21406390 | |
437 | Phosphorylation | QKLNSLMSLVNKTTH HHHHHHHHHHHHHHH | 34.16 | 21712546 | |
441 | Acetylation | SLMSLVNKTTHLIAK HHHHHHHHHHHHHHH | 47.52 | 25953088 | |
441 | Ubiquitination | SLMSLVNKTTHLIAK HHHHHHHHHHHHHHH | 47.52 | - | |
448 | 2-Hydroxyisobutyrylation | KTTHLIAKEEMIHNL HHHHHHHHHHHHHHC | 47.41 | - | |
448 | Acetylation | KTTHLIAKEEMIHNL HHHHHHHHHHHHHHC | 47.41 | 23749302 | |
448 | Malonylation | KTTHLIAKEEMIHNL HHHHHHHHHHHHHHC | 47.41 | 26320211 | |
448 | Ubiquitination | KTTHLIAKEEMIHNL HHHHHHHHHHHHHHC | 47.41 | 21890473 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PSD12_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PSD12_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PSD12_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 2-12, AND ACETYLATION AT ALA-2. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221; LYS-368 AND LYS-448,AND MASS SPECTROMETRY. |